Improving conduct and feasibility of clinical trials to evaluate antibacterial drugs to treat hospital acquired bacterial pneumonia (HABP) and ventilator associated bacterial pneumonia (VABP): recommendations of the CTTI Antibacterial Drug Development (abdd) Project Team

相似书籍

• Streamlining safety data collection in hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) trials: recommendations of the CTTI Antibacterial Drug Development (ABDD) Project Team
  由: Donnelly, H, et al.
  出版: (2016)
• Streamlining safety data collection in hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia trials: recommendations of the Clinical Trials Transformation Initiative Antibacterial Drug Development Project Team
  由: Donnelly, H, et al.
  出版: (2016)
• Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP)
  由: Francesco Saverio Mennini, et al.
  出版: (2022-04-01)
• The risk of inappropriate empiric treatment and its outcomes based on pathogens in non-ventilated (nvHABP), ventilated (vHABP) hospital-acquired and ventilator-associated (VABP) bacterial pneumonia in the US, 2012–2019
  由: Marya D. Zilberberg, et al.
  出版: (2022-10-01)
• A phase III, randomized, controlled noninferiority trial to study the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) vs piperacillin/tazobactam (PIP/TAZ) in patients with hospital-acquired bacterial pneumonia (HABP) or ventilator-associated bacterial pneumonia (VABP)
  由: Junjie Li, et al.
  出版: (2025-04-01)